We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-1.12%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$63.3B
AUM Growth
+$192M
Cap. Flow
+$1.33B
Cap. Flow %
2.1%
Top 10 Hldgs %
14.31%
Holding
4,981
New
573
Increased
1,406
Reduced
1,427
Closed
1,256

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$561M
2
ACN icon
Accenture
ACN
+$435M
3
MRK icon
Merck
MRK
+$378M
4
NOC icon
Northrop Grumman
NOC
+$339M
5
V icon
Visa
V
+$308M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$439M
2
ZTS icon
Zoetis
ZTS
+$345M
3
MCD icon
McDonald's
MCD
+$343M
4
UNH icon
UnitedHealth
UNH
+$334M
5
SPGI icon
S&P Global
SPGI
+$279M

Sector Composition

Rank Sector Weight
1 Technology 17.86%
2 Industrials 11.25%
3 Healthcare 10.23%
4 Financials 10.22%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALL icon
3751
PUT
Allstate
ALL
$67.3B
-2,300
Closed -$398K
ALNY icon
3752
Alnylam Pharmaceuticals
ALNY
$37.2B
-110,759
Closed -$16.6M
ALTG icon
3753
Alta Equipment Group
ALTG
$208M
-41,503
Closed -$537K
AMBA icon
3754
Ambarella
AMBA
$2.99B
-48,817
Closed -$2.48M
OSG
3755
Octave Specialty Group
OSG
$258M
-64,576
Closed -$1.01M
AMCX icon
3756
AMC Global Media
AMCX
$445M
-23,969
Closed -$291K
AMCR icon
3757
Amcor
AMCR
$20.9B
-1,853
Closed -$88.1K
AMLX icon
3758
PUT
Amylyx Pharmaceuticals
AMLX
$2.17B
-15,600
Closed -$44.3K
AMPL icon
3759
Amplitude
AMPL
$1.15B
-2,614
Closed -$28.4K
AMRN
3760
Amarin Corp
AMRN
$290M
-63
Closed -$1.12K
AMRC icon
3761
Ameresco
AMRC
$1.12B
-22,888
Closed -$552K
AMTX icon
3762
Aemetis
AMTX
$109M
-117,726
Closed -$705K
AMX icon
3763
America Movil
AMX
$77.1B
-53,395
Closed -$996K
ANAB icon
3764
AnaptysBio
ANAB
$1.59B
-28,542
Closed -$643K
ANET icon
3765
CALL
Arista Networks
ANET
$215B
-4,400
Closed -$319K
ANET icon
3766
PUT
Arista Networks
ANET
$215B
-3,600
Closed -$261K
AOD
3767
abrdn Total Dynamic Dividend Fund
AOD
$1.1B
-115,621
Closed -$958K
AOMR
3768
Angel Oak Mortgage REIT
AOMR
$222M
-19
Closed -$204
AON icon
3769
CALL
Aon
AON
$78.4B
-4,700
Closed -$1.57M
AORT icon
3770
Artivion
AORT
$1.27B
-10,038
Closed -$212K
APA icon
3771
CALL
APA Corp
APA
$12.3B
-1,000
Closed -$34.4K
APA icon
3772
PUT
APA Corp
APA
$12.3B
-4,100
Closed -$141K
APD icon
3773
CALL
Air Products & Chemicals
APD
$65.2B
-700
Closed -$170K
APD icon
3774
PUT
Air Products & Chemicals
APD
$65.2B
-400
Closed -$96.9K
APGE icon
3775
Apogee Therapeutics
APGE
$10.2B
-2,264
Closed -$150K

Similar funds

Qube Research & Technologies (QRT)'s Q2 2024 Portfolio in Review

As of Q2 2024, Qube Research & Technologies (QRT) held 4,981 positions worth $63.3B, up 0.3% from $63.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Qube Research & Technologies (QRT)'s Q2 2024 filing shows 573 new, 1,406 increased, 1,427 reduced and 1,256 closed positions. Its largest new stake was Coinbase: 273,144 shares worth $60.7M. The largest sale was NVIDIA, an estimated $439M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.

  • Qube Research & Technologies (QRT)'s largest Q2 2024 buy was Coinbase: 273,144 shares worth $60.7M.
  • Qube Research & Technologies (QRT) added most to Broadcom in Q2 2024, an estimated $561M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2024 reduction was NVIDIA, cutting an estimated $439M.
  • Qube Research & Technologies (QRT) fully exited Palantir in Q2 2024, selling an estimated $161M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 14% of its $63.3B portfolio in Q2 2024.
  • Qube Research & Technologies (QRT) opened 573 new positions and closed 1,256 in Q2 2024.
  • Qube Research & Technologies (QRT)'s portfolio value rose 0.3% quarter-over-quarter to $63.3B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.